Idrabiotaparinux 

Idrabiotaparinux, a derivative of Idraparinux (HY-19691), is a novel synthetic anticoagulant that links Idraparinux, a specific, indirect factor Xa inhibitor, to biotin^[1][2].

1853.78

C₅₃H₈₈N₄O₅₁S₈

774531-07-6

O=S(O[C@H]([C@H]([C@@H](O[C@@]1([H])[C@@H]([C@H]([C@H](O[C@@]2([H])[C@@H]([C@H]([C@@H](OC)O[C@@H]2COS(=O)(O)=O)OS(=O)(O)=O)OS(=O)(O)=O)O[C@H]1C(O)=O)OC)OC)O[C@@H]3COS(=O)(O)=O)OS(=O)(O)=O)[C@]3([H])O[C@H]4[C@@H]([C@H]([C@@](O[C@@H]5[C@@H]([C@H]([C@H](OC)[C@@H](COS(=O)(O)=O)O5)OC)NC(CCCCCNC(CCCC[C@H]6[C@](N7)([H])[C@](NC7=O)([H])CS6)=O)=O)([H])[C@@H](C(O)=O)O4)OC)OC)(O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Job Harenberg. Idraparinux and idrabiotaparinux. Expert Rev Clin Pharmacol. 2010 Jan;3(1):9-16.  [Content Brief]

  [2]. Harry Roger Buller, et al. Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin. Blood (2008) 112 (11): 32.